Inspite of its shortcomings, the fact that the coverage is currently being rolled out as a trial can be a beneficial point, reckons Michel Kazatchkine, a member of the Global Commission on Drug Plan. The strongest way to convince naysayers is thru delivering cold, tough, irrefutable proof, he states, and The simplest way to do that is by means of s